Brief Report
High seroprevalence of hepatitis E virus in the Free State province of South Africa
Submitted: 20 September 2023 | Published: 25 March 2024
About the author(s)
Sindiswa S. Maphumulo, Department of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa; and Department of Virology, National Health Laboratory Service, Bloemfontein, South AfricaDominique Goedhals, Department of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa; Department of Virology, National Health Laboratory Service, Bloemfontein, South Africa; and Department of Virology, PathCare Laboratory, Pretoria, South Africa
Cornel van Rooyen, Department of Biostatistics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
Sabeehah Vawda, Department of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa; Department of Virology, National Health Laboratory Service, Bloemfontein, South Africa; and Department of Virology, PathCare Laboratory, Pretoria, South Africa
Abstract
The seroepidemiology of hepatitis E virus (HEV) in South Africa is limited. We investigated anti-HEV IgM and IgG, in residual hepatitis A, B, and C negative serology specimens, at our public sector Free State (FS) laboratory. Of 299 specimens (01 May–31 October 2020), 182/299 (60.9%) had anti-HEV IgG and 1/299 (0.33%) had anti-HEV IgM. High HEV seroprevalence across different age groups suggests a different epidemiology in the FS, necessitating further research.
Contribution: The need for HEV research in South Africa is highlighted. Clinicians should consider HEV in their differential diagnosis of patients with hepatitis.
Keywords
Metrics
Total abstract views: 1069Total article views: 1064